Lobbying Relationship

Client

GeneDx, Inc.

More records

Lobbying firm

iPolicy Solutions

More records

  • HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S.4348 - FDASLA Act of 2022

Duration: to

General Issues: Medical/Disease Research/Clinical Labs, Medicare/Medicaid

Spending: about $52,500 (But it's complicated. Here's why.)

Agencies lobbied since 2021: U.S. Senate, House of Representatives

Bills mentioned

H.R.4128: VALID Act of 2021

Sponsor: Diana DeGette (D-Colo.)

S.2209: VALID Act of 2021

Sponsor: Richard M. Burr (R-N.C.)

S.4348: FDASLA Act of 2022

Sponsor: Patty Murray (D-Wash.)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Jennifer Leib Fellow, Senate Committee on Health, Education, Labor and Pensions Fellow, Senate Health, Education, Labor, and Pensions Committee
Megan Anderson Brooks n/a
Jay Qiu n/a

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Termination
Q2 Report
Q1 Report
Registration
Q4 Report

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page